- Location
Heart Failure Treatment
"-
Transcatheter Heart Failure Treatment to European Clinical Site Was Expanded by Bioventrix
Dec 16, 2013US-based BioVentrix has announced that placement of its Revivent-TC ventricular enhancement system, via Less Invasive Ventricular Enhancement (LIVE) procedure, has been successfully expanded to a second European clinical site. The ...
-
A Meta-Analysis Found Exercise May Be as Effective Drugs in Helping Patients with Strokes
Dec 14, 2013A meta-analysis found exercise may be as effective as drugs in helping patients with strokes, diabetes and heart disease, British and U.S. researchers say. Researchers at the London School of Economics and Political Science, the Harvard ...
-
Sorin Group Hold The Post of Neurostimulation Devices Developer
Dec 18, 2012Sorin Group, a manufacturer of medical technologies for cardiac surgery, has purchased Neurotech to expand its market of neuromodulation therapies for treating heart failure. Neurotech's commercial products include implantable medical ...
Tags: cardiac surgery, medical technology, expansion, medical device
-
CircuLite Obtained CE Mark for New Micro-Blood Pump Synergy Circulatory Support System
Sep 6, 2012CircuLite has obtained CE mark for its new micro-blood pump Synergy Circulatory Support system, designed to treat ambulatory heart failure patients (INTERMACS 4,5,6 / NYHA IIIB and early IV). The Synergy system, which is implanted ...
Related Products
-
High Quality Levosimendan CAS 141505-33-1 Treatment of Acute Heart Failure
-
High Quality Antibiotic Mizoribine CAS 50924-49-7 with Good Price
-
Best Price Lcz696 Powder CAS 936623-90-4 Lcz696 for Treatment of Heart Failure
-
Heart Failure Treatment Elamipretide Tfa CAS 1606994-55-1 Ss-31 Peptide
-
Lcz696 Entresto CAS 936623-90-4 for The Treatment of Patients with Heart Failure
-
Lcz696 Is a Drug for The Treatment of Heart Failure CAS: 936623-90-4
